Literature DB >> 32581085

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak.

Ho So1, Cheuk-Chun Szeto2, Lai-Shan Tam2.   

Abstract

Entities:  

Keywords:  health services research; lupus erythematosus; lupus nephritis; systemic

Mesh：

Year:  2020        PMID： 32581085     DOI： 10.1136/annrheumdis-2020-218220

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.

Authors:  Lai-Shan Tam; Yoshiya Tanaka; Rohini Handa; Zhanguo Li; Jose Paulo Lorenzo; Worawit Louthrenoo; Catherine Hill; Kevin Pile; Philip C Robinson; Leonila F Dans; Li Yang Hsu; Sang-Min Lee; Jiacai Cho; A T M Tanveer Hasan; Babur Salim; Saba Samreen; Syahrul Sazliyana Shaharir; Priscilla Wong; Jeffrey Chau; Debashish Danda; Syed Atiqul Haq
Journal:  Int J Rheum Dis       Date:  2021-05-04       Impact factor: 2.454

2.  Factors Associated With Use of Telemedicine for Follow-Up of SLE in the COVID-19 Outbreak.

Authors:  Ho So; Evelyn Chow; Isaac T Cheng; Sze-Lok Lau; Tena K Li; Cheuk-Chun Szeto; Lai-Shan Tam
Journal:  Front Med (Lausanne)       Date:  2021-12-13

Review 3.  COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis.

Authors:  Bohdana Doskaliuk; Roman Yatsyshyn; Iryna Klishch; Olena Zimba
Journal:  Rheumatol Int       Date:  2021-10-01       Impact factor: 2.631

4.  Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial.

Authors:  Ho So; Evelyn Chow; Isaac T Cheng; Sze-Lok Lau; Tena K Li; Cheuk-Chun Szeto; Lai-Shan Tam
Journal:  Lupus       Date:  2022-03-07       Impact factor: 2.911

5.  Telemedicine for Rheumatology Patients in Covid-19 Pandemic: Perspectives of Patients.

Authors:  Muhammad Mehmood Riaz; Saad Bin Zafar Mahmood; Noreen Nasir
Journal:  J Patient Exp       Date:  2022-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.